This implies a potential interplay or cross-regulation between mitochondrial function and Akt signaling pathways, suggesting that targeting POLRMT with IMT1 might influence both mitochondrial activity and downstream Akt-mTOR signaling pathways, thereby strongly inhibiting CRC cell growth in vitro and in vivo (Fig. 10). Here, MTOR is linked to colorectal carcinoma.